Jefferies Upgrades Nanosphere (NSPH) to Buy; Test Approval Removes Overhangs

Article Stock Quotes (1) Comments (0)

Jefferies upgraded Nanosphere (NASDAQ: NSPH) from Hold to Buy with a price target of $5.00 (from $2.00).

Analyst, Jon Wood, said, "We are upgrading NSPH on expectations for its recently FDA approved gram-positive blood stream infection test to drive a significant acceleration in new system placements & revenue. We are raising our 2012 & 2013 revenue forecasts to $9.5M (from $9M) and $28M (from $20M), respectively."

For an analyst ratings summary and ratings history on Nanosphere click here. For more ratings news on Nanosphere click here.

Shares of Nanosphere closed at $2.52 yesterday, with a 52 week range of $0.89-$2.59.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Goldman Sachs Upgrades Meritor (MTOR) to Buy
• UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
• Iberia Capital Upgrades James River Coal (JRCC) to Outperform

Create E-mail Alert Related Categories

FDA, Upgrades

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?